264 related articles for article (PubMed ID: 10866040)
21. A pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellation.
Favero CB; Mandell JW
Brain Res; 2007 Sep; 1168():1-10. PubMed ID: 17706943
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.
Leclerc I; Lenzner C; Gourdon L; Vaulont S; Kahn A; Viollet B
Diabetes; 2001 Jul; 50(7):1515-21. PubMed ID: 11423471
[TBL] [Abstract][Full Text] [Related]
23. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.
Salt IP; Johnson G; Ashcroft SJ; Hardie DG
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):533-9. PubMed ID: 9794792
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
Lochhead PA; Coghlan M; Rice SQ; Sutherland C
Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
[TBL] [Abstract][Full Text] [Related]
25. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
26. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.
Horike N; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Kamata H; Nishiyama K; Uchijima Y; Kurihara Y; Kurihara H; Asano T
J Biol Chem; 2008 Dec; 283(49):33902-10. PubMed ID: 18801732
[TBL] [Abstract][Full Text] [Related]
27. The 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex.
Leclerc I; Kahn A; Doiron B
FEBS Lett; 1998 Jul; 431(2):180-4. PubMed ID: 9708898
[TBL] [Abstract][Full Text] [Related]
28. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
Yarushkin AA; Kachaylo EM; Pustylnyak VO
Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
[TBL] [Abstract][Full Text] [Related]
29. Activation of AMP-activated protein kinase stimulates proopiomelanocortin gene transcription in AtT20 corticotroph cells.
Iwasaki Y; Nishiyama M; Taguchi T; Kambayashi M; Asai M; Yoshida M; Nigawara T; Hashimoto K
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1899-905. PubMed ID: 17341551
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
31. AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus.
Gadalla AE; Pearson T; Currie AJ; Dale N; Hawley SA; Sheehan M; Hirst W; Michel AD; Randall A; Hardie DG; Frenguelli BG
J Neurochem; 2004 Mar; 88(5):1272-82. PubMed ID: 15009683
[TBL] [Abstract][Full Text] [Related]
32. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
33. AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase.
Kefas BA; Heimberg H; Vaulont S; Meisse D; Hue L; Pipeleers D; Van de Casteele M
Diabetologia; 2003 Feb; 46(2):250-4. PubMed ID: 12627324
[TBL] [Abstract][Full Text] [Related]
34. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
[TBL] [Abstract][Full Text] [Related]
35. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
36. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
Cuthbertson DJ; Babraj JA; Mustard KJ; Towler MC; Green KA; Wackerhage H; Leese GP; Baar K; Thomason-Hughes M; Sutherland C; Hardie DG; Rennie MJ
Diabetes; 2007 Aug; 56(8):2078-84. PubMed ID: 17513706
[TBL] [Abstract][Full Text] [Related]
37. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.
Kurth-Kraczek EJ; Hirshman MF; Goodyear LJ; Winder WW
Diabetes; 1999 Aug; 48(8):1667-71. PubMed ID: 10426389
[TBL] [Abstract][Full Text] [Related]
38. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
39. 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling.
Su RY; Chao Y; Chen TY; Huang DY; Lin WW
Mol Cancer Ther; 2007 May; 6(5):1562-71. PubMed ID: 17513605
[TBL] [Abstract][Full Text] [Related]
40. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
